A Phase 2 Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Booster Dose of a Group B Streptococcus 6-Valent Polysaccharide Conjugate Vaccine (GBS6)

Authors
Category Primary study
JournalOpen Forum Infectious Diseases
Year 2022
This article has no abstract
Epistemonikos ID: b7fd451ac40a7cbeaa42b56c190bf13a9eafa9f3
First added on: Feb 15, 2025